PLx Pharma Inc.·4

Mar 16, 8:33 AM ET

O'Connor Rita M 4

4 · PLx Pharma Inc. · Filed Mar 16, 2022

Insider Transaction Report

Form 4
Period: 2022-03-15
O'Connor Rita M
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-03-15$3.65/sh+3,700$13,52226,670 total
  • Purchase

    Common Stock

    2022-03-15$3.66/sh+10,000$36,60022,970 total

Documents

1 file
  • 4
    form411577oco_03162022.xmlPrimary

    OWNERSHIP DOCUMENT